Related Experiment Video
Updated: Dec 10, 2025

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T
Gladys N Macharia1,2, Ling Yue3, Ecco Staller1,2
1Department of Medicine, Imperial College London, London, United Kingdom.
Insights
Multivariant HIV-1 infection, common in men who have sex with men (MSM), is linked to lower gag replicative capacity and faster CD4+ T cell decline. Strategies to reduce multiple variant infections may improve HIV-1 prognosis and aid vaccine development.
Area of Science:
- Virology
- Immunology
- Epidemiology
Background:
- HIV-1 transmission involves a genetic bottleneck, with limited variants establishing infection.
- The IAVI Protocol C cohort provides a unique opportunity to study transmitted/founder (TF) viruses in diverse risk groups.
Purpose of the Study:
- To characterize transmitted/founder (TF) HIV-1 viruses in men who have sex with men (MSM).
- To assess the impact of multivariant infection on viral replicative capacity and disease progression.
- To evaluate the role of TF viruses in predicting disease outcome and immune response.
Main Methods:
- Sequencing of HIV-1 repertoire in MSM participants near transmission.
- Generation and characterization of chimeric viruses using patient-derived gag genes.
- Evaluation of TF virus impact on disease progression and immune responses.
Main Results:
- Higher prevalence of multivariant HIV-1 infection observed in MSM compared to heterosexual cohorts.
- Multivariant infection associated with lower replicative capacity of TF gag genes (p = 0.02).
- Multivariant infection linked to rapid CD4+ T cell decline and immune cell disturbances, reversible upon viremia control.
Conclusions:
- Multivariant infection in MSM impacts viral fitness and accelerates disease progression.
- Strategies to tighten the transmission bottleneck, like STI treatment, could improve HIV-1 prognosis.
- TF sequences and chimeric viruses are valuable for vaccine immunogen design and immune response studies.
Abstract:
HIV-1 transmission is associated with a severe bottleneck in which a limited number of variants from a pool of genetically diverse quasispecies establishes infection. The IAVI protocol C cohort of discordant couples, female sex workers, other heterosexuals and men who have sex with men (MSM) present varying risks of HIV infection, diverse HIV-1 subtypes and represent a unique opportunity to characterize transmitted/founder viruses (TF) where disease outcome is known. To identify the TF, the HIV-1 repertoire of 38 MSM participants' samples was sequenced close to transmission (median 21 days post infection, IQR 18-41) and assessment of multivariant infection done. Patient derived gag genes were cloned into an NL4.3 provirus to generate chimeric viruses which were characterized for replicative capacity (RC). Finally, an evaluation of how the TF virus predicted disease progression and modified the immune response at both acute and chronic HIV-1 infection was done. There was higher prevalence of multivariant infection compared with previously described heterosexual cohorts. A link was identified between multivariant infection and replicative capacity conferred by gag, whereby TF gag tended to be of lower replicative capacity in multivariant infection (p = 0.02) suggesting an overall lowering of fitness requirements during infection with multiple variants. Notwithstanding, multivariant infection was associated with rapid CD4+ T cell decline and perturbances in the CD4+ T cell and B cell compartments compared to single variant infection, which were reversible upon control of viremia. Strategies aimed at identifying and mitigating multivariant infection could contribute toward improving HIV-1 prognosis and this may involve strategies that tighten the stringency of the transmission bottleneck such as treatment of STI. Furthermore, the sequences and chimeric viruses help with TF based experimental vaccine immunogen design and can be used in functional assays to probe effective immune responses against TF.
Related Concept Videos
Size and Structure of Viral Genomes
Viral Mutations
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Retrovirus Life Cycles
Viral Recombination

